Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Serotonin type 3-receptor antagonists for chemotherapy-induced nausea and vomiting: therapeutically equivalent or meaningfully different?

× No keyword cloud information.

17 in total

Review 1. ASHP Therapeutic Guidelines on the Pharmacologic Management of Nausea and Vomiting in Adult and Pediatric Patients Receiving Chemotherapy or Radiation Therapy or Undergoing Surgery.

Authors:
Journal: Am J Health Syst Pharm Date: 1999-04-15 Impact factor: 2.637

Review 2. Antiemetics: American Society of Clinical Oncology clinical practice guideline update.

Authors: Ethan Basch; Ann Alexis Prestrud; Paul J Hesketh; Mark G Kris; Petra C Feyer; Mark R Somerfield; Maurice Chesney; Rebecca Anne Clark-Snow; Anne Marie Flaherty; Barbara Freundlich; Gary Morrow; Kamakshi V Rao; Rowena N Schwartz; Gary H Lyman
Journal: J Clin Oncol Date: 2011-09-26 Impact factor: 44.544

Review 3. Evidence to support use of palonosetron over generic serotonin type 3-receptor antagonists for chemotherapy-induced nausea and vomiting.

Authors: Yu-Chen Yeh; Gayle C Blouin; Prabashni Reddy
Journal: Am J Health Syst Pharm Date: 2014-03-15 Impact factor: 2.637

4. Efficacy of ondansetron (GR 38032F) and the role of serotonin in cisplatin-induced nausea and vomiting.

Authors: L X Cubeddu; I S Hoffmann; N T Fuenmayor; A L Finn
Journal: N Engl J Med Date: 1990-03-22 Impact factor: 91.245

5. A phase III, double-blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy.

Authors: M S Aapro; S M Grunberg; G M Manikhas; G Olivares; T Suarez; S A Tjulandin; L F Bertoli; F Yunus; B Morrica; F Lordick; A Macciocchi
Journal: Ann Oncol Date: 2006-06-09 Impact factor: 32.976

Review 6. Comparative efficacy and safety of palonosetron with the first 5-HT3 receptor antagonists for the chemotherapy-induced nausea and vomiting: a meta-analysis.

Authors: Y Jin; W Sun; D Gu; J Yang; Z Xu; J Chen
Journal: Eur J Cancer Care (Engl) Date: 2012-04-22 Impact factor: 2.520

7. Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron.

Authors: R Gralla; M Lichinitser; S Van Der Vegt; H Sleeboom; J Mezger; C Peschel; G Tonini; R Labianca; A Macciocchi; M Aapro
Journal: Ann Oncol Date: 2003-10 Impact factor: 32.976

8. Improved prevention of moderately emetogenic chemotherapy-induced nausea and vomiting with palonosetron, a pharmacologically novel 5-HT3 receptor antagonist: results of a phase III, single-dose trial versus dolasetron.

Authors: Peter Eisenberg; Jazmin Figueroa-Vadillo; Rosalio Zamora; Veena Charu; Julio Hajdenberg; Alan Cartmell; Alberto Macciocchi; Steven Grunberg
Journal: Cancer Date: 2003-12-01 Impact factor: 6.860

9. Changes in serotonin metabolism in cancer patients: its relationship to nausea and vomiting induced by chemotherapeutic drugs.

Authors: L X Cubeddu; I S Hoffmann; N T Fuenmayor; J J Malave
Journal: Br J Cancer Date: 1992-07 Impact factor: 7.640

10. Use and cardiovascular safety of transdermal and other granisetron preparations in cancer management.

Authors: Jay W Mason; Thomas E Moon
Journal: Cancer Manag Res Date: 2013-07-29 Impact factor: 3.989

2 in total

Review 1. Palonosetron in the management of chemotherapy-induced nausea and vomiting in patients receiving multiple-day chemotherapy.

Authors: Mary Lou Affronti; Joseph Bubalo
Journal: Cancer Manag Res Date: 2014-09-05 Impact factor: 3.989

Review 2. Recent advances in antiemetics: new formulations of 5HT₃-receptor antagonists.

Authors: James Gilmore; Steven D'Amato; Niesha Griffith; Lee Schwartzberg
Journal: Cancer Manag Res Date: 2018-07-03 Impact factor: 3.989